|
CN112062684A
|
|
Method for purifying salbutamol intermediate IV
|
|
CN112083088A
|
|
GC-MS combined detection method for N-nitrosodimethylamine in metformin hydrochloride sustained-release tablets
|
|
CN112083089A
|
|
Method for detecting dissolution curve of telmisartan tablets
|
|
CN111870585A
|
|
Metformin hydrochloride controlled release tablet and preparation method thereof
|
|
CN111759815A
|
|
Metformin hydrochloride controlled-release tablet core and preparation method thereof
|
|
CN111840242A
|
|
Metformin hydrochloride controlled release tablet and preparation method thereof
|
|
CN111759849A
|
|
Anti-angina pectoris pharmaceutical composition and preparation method and application thereof
|
|
CN111759818A
|
|
Metformin hydrochloride sustained release tablet and preparation method thereof
|
|
CN111700866A
|
|
Preparation method of telmisartan tablets
|
|
CN111603453A
|
|
Preparation method of glimepiride tablet
|
|
CN111658627A
|
|
Method for quickly dissolving metformin hydrochloride
|
|
CN111689969A
|
|
Preparation method of sildenafil
|
|
CN111544411A
|
|
Preparation method of telmisartan tablets
|
|
CN111808027A
|
|
Purification method of telmisartan intermediate
|
|
CN111265488A
|
|
Telmisartan tablets and preparation method thereof
|
|
CN111249243A
|
|
Telmisartan tablets and preparation method thereof
|
|
CN111249244A
|
|
Gliclazide controlled release tablet and preparation method thereof
|
|
CN111228227A
|
|
Salbutamol sulfate oral disintegrating tablet and preparation method thereof
|
|
CN111450071A
|
|
Metformin hydrochloride tablet and preparation method thereof
|
|
CN111170948A
|
|
Purification method of telmisartan
|
